跳至主要内容
临床试验/NCT02231268
NCT02231268已完成不适用

Observational Study Via Internet to Assess a 6-months Treatment With GLADEM

Boehringer Ingelheim0 个研究点目标入组 546 人开始时间: 2000年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
546
主要终点
Change in Hamilton Depression Scale (HAMD-6)

研究概览

简要总结

  • Evaluation of a 6-months treatment with Gladem
  • Experiences with the internet for performing a postmarketing study (PMS) trial

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women at least 18 years old
  • De novo prescription of Gladem
  • Treatment with Gladem intended for at least 6 months
  • Depressive disorders

排除标准

  • Known hypersensitivity against sertraline
  • Concomitant treatment with monoamine oxidase (MAO)-inhibitors, selegiline, moclobemide (washout for at least 14 days necessary)
  • Concomitant treatment with other serotoninergic substances like tryptophan or fenfluramine
  • Instable epilepsy
  • According to product information (October 1998) Gladem prescription was possible with precautions in the following cases:
  • Patients with stable epilepsy
  • Patients with restricted liver functions
  • Suicidal patients
  • Patients in emotional state and marked sleeping disorders
  • According to product information (October 1998) Gladem should only be prescribed during pregnancy and lactation period, if the expected benefit was greater than the risk. Women of childbearing age should use Gladem only in combination with sufficient contraception.

研究组 & 干预措施

Depressive patients

干预措施: Gladem (Drug)

结局指标

主要结局

Change in Hamilton Depression Scale (HAMD-6)

时间窗: 3 months, 6 months

次要结局

  • Global assessment of tolerability on a 4-point scale(up to 6 months)
  • Number of responders(up to 6 months)
  • Change in HAMD subscores(baseline, 6 months)
  • Global assessment of compliance on a 4-point scale(up to 6 months)
  • Global assessment of efficacy on a 4-point scale(up to 6 months)
  • Clinical global impression score(up to 6 months)
  • Number of patients with adverse drug reactions(up to 6 months)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Observational Study to Assess a 6-months Treatment... | 临床试验